Microscopic Venous Infiltration As Predictor Of Relapse In Renal Cell Carcinoma
- 1 August 1992
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 148 (2), 271-274
- https://doi.org/10.1016/s0022-5347(17)36569-2
Abstract
In a retrospective analysis at a single institution we evaluated the significance of various pathological phenomena on the disease-free survival of patients with radically resected renal cell carcinoma. Parameters considered were tumor extension (pT stage) according to the International Union Against Cancer, tumor invasion into the renal vein or vena cava (V stage), standard histological grading (G stage), nuclear grading (F stage) and microscopic venous infiltration. The pT stage had a significant impact on disease-free survival (p = 0.0004) of patients with radically resected tumors, as did G stage (p = 0.0001) and F stage (p = 0.002). In contrast to some previously reported results tumor extension to the renal vein and vena cava showed no influence on disease-free survival (p = 0.077). On the other hand, microscopic venous infiltration, defined as local tumor infiltration through all vessel structures including the endothelial layer leading to a free tumor extension into the vessel, had a significant impact on disease-free survival (p < 0.0001). When stratifying either tumor size or nuclear differentiation against microscopic venous infiltration, the latter retained a superior influence on disease-free survival (p = 0.01 and p = 0.0079, respectively). We conclude that microscopic venous infiltration is the most important predictor of relapse in renal cell carcinoma.Keywords
This publication has 16 references indexed in Scilit:
- Evaluation of the New Tumor, Nodes and Metastases Classification of Renal Cell CarcinomaJournal of Urology, 1990
- Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.Journal of Clinical Oncology, 1989
- Renal cell carcinoma.Prognostic significance of morphologic parameters in 121 casesCancer, 1988
- Phase I/II Study of Recombinant Interferon Gamma in Advanced Renal Cell CarcinomaJournal of Urology, 1988
- Selection of initial therapy for renal cell carcinomaCancer, 1987
- Treatment of Advanced Renal Cell Carcinoma—Traditional Methods and Innovative ApproachesJournal of Urology, 1983
- Prognostic significance of morphologic parameters in renal cell carcinomaThe American Journal of Surgical Pathology, 1982
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971
- Renal Adenocarcinoma: 28-year Review, with Emphasis on Rationale and Feasibility of Preoperative RadiotherapyJournal of Urology, 1970
- The Results of Radical Nephrectomy for Renal Cell CarcinomaJournal of Urology, 1969